May 10, 2004 Issue | Chemical & Engineering News
 
Copyright © 2004 American Chemical Society
 

May 10, 2004 Issue

Volume 82, Issue 19
8219cov1a
May 10, 2004 Issue, Vol. 82 | Iss. 19
'Big pharma' is weaving biotech into its research regime, developing multiple therapeutic indications for protein drugs
By Rick Mullin
(pp. 19-25)
Features
Government & Policy
Presidential directive, ‘hot’ labs to prepare U.S. for bioterrorism 
Science & Technology
Chemists gather to paint a 21st-century picture of the resurgent field of main-group chemistry (pp. 39-42)
Back Issues
 

Cover Story: BIOPHARMACEUTICALS

A NEW BATTLEFIELD IN BIOLOGICS
Having achieved capacity balance, contract service firms move into life-cycle management
(pp. 26-27)
 

News of the Week

NEW STRATEGY, NEW LABS

Presidential directive, ‘hot’ labs to prepare U.S. for bioterrorism
(p.9)

PLASTIC FALLOUT IN THE OCEANS

Microscopic polymer bits are accumulating in marine environments
(p.10)

SAUDI SHOOTING SPURS ANXIETY

Petrochemical firms may rethink projects after attack on Yanbu facility
(p.10)

ACS INSTITUTE GETS NEW DIRECTOR

Paul Anastas will take the helm of Green Chemistry institute in June
(p.13)

LEADING SCIENCE INDICATORS

NSB report shows U.S. leadership in science and technology faces hurdles
(p.13)
 

Departments

Business

Having achieved capacity balance, contract service firms move into life-cycle management
(pp. 26-27)
'Big pharma' is weaving biotech into its research regime, developing multiple therapeutic indications for protein drugs
(pp. 19-25)
Cedarburg founders turn to venture-capital funding and find they like it
(p.16)
Corning's chief technology officer chose new challenges over retirement to academia
(p.16)

ACS News

(pp. 51-52)
(p.53)
8219gov1_opn_tif

Government & Policy

U.S., EU share views on regulation at trans-Atlantic conference on chemicals
(pp. 29-31)
Lapses in disclosures and delays in chemical arms destruction prompt proliferation fears
(pp. 33-35)
Build more usable nuclear weapons or work to eliminate them all: A debate that needs to be joined
(p.36)

Science & Technology

Chemists gather to paint a 21st-century picture of the resurgent field of main-group chemistry
(pp. 39-42)
Frailty, erectile dysfunction, scarring, and thrombosis/atherosclerosis drugs introduced
(pp. 43-45)
New computational methods for drug design improve modeling of receptor-ligand interactions
(pp. 46-47)
NEW AND NOTABLE IN THE CHEMICAL INDUSTRY
(p.48)